Paravasthu Mukund 4
4 · NovoCure Ltd · Filed Nov 4, 2025
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Paravasthu Mukund
Chief Operating Officer
Transactions
- Tax Payment
Ordinary Shares
2025-11-04$12.23/sh−2,949$36,066→ 80,439 total - Tax Payment
Ordinary Shares
2025-11-01$12.81/sh−168$2,152→ 83,388 total
Footnotes (1)
- [F1]Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1).